Doctor's views on disclosing or withholding information on low risks of complication

Por Palmboom, G G, Willems, D L, Janssen, N B A T, de Haes, J C J M
Publicado em 2007

Parental attitude towards genetic testing for familial hypercholesterolaemia in children

Por Umans-Eckenhausen, M, Oort, F, Ferenschild, K, Defesche, J, Kastelein, J, de Haes, J C J M
Publicado em 2002

A randomized controlled trial of a skills training for oncologists and a communication aid for patients to stimulate shared decision making about palliative systemic treatment (CHO...

Por Henselmans, I., Smets, E. M. A., de Haes, J. C. J. M., Dijkgraaf, M. G. W., de Vos, F. Y., van Laarhoven, H. W. M.
Publicado no BMC Cancer (2018)

Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice

Por Koedoot, C G, de Haan, R J, Stiggelbout, A M, Stalmeier, P F M, de Graeff, A, Bakker, P J M, de Haes, J C J M
Publicado em 2003

Assessing cancer patients' trust in their oncologist: development and validation of the Trust in Oncologist Scale (TiOS)

Por Hillen, M. A., Koning, C. C. E., Wilmink, J. W., Klinkenbijl, J. H. G., Eddes, E. H., Kallimanis-King, B. L., de Haes, J. C. J. M., Smets, E. M. A.
Publicado em 2011

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences

Por de Boer, A G E M, Stalmeier, P F M, Sprangers, M A G, de Haes, J C J M, van Sandick, J W, Hulscher, J B F, van Lanschot, J J B
Publicado em 2002

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study

Por van Nes, J. G. H., Fontein, D. B. Y., Hille, E. T. M., Voskuil, D. W., van Leeuwen, F. E., de Haes, J. C. J. M., Putter, H., Seynaeve, C., Nortier, J. W. R., van de Velde, C. J. H.
Publicado em 2012